SAMUEL GEORGE A. III (General Counsel/Secretary) received a stock award from LINEAGE CELL THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/19/2025ACC: 0001193125-25-327279
Officer· General Counsel/Secretary
Since Sep 2021
+1.67K
Net shares
Net buyer
$109.20
Total sold
0
Open market trades
0B · 0S
2
Total transactions
1.74K acquired · 65.00 disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+1.74K
Price / share
—
Trade value
—
% of position
6.7%
12/19/2025
25.82K→27.55K
Common Shares
Direct
Shares
−65.00
Price / share
$1.68
Trade value
$109.20
% of position
0.2%
12/19/2025
27.55K→27.49K
Total
Net shares
+1.67K
Net value
-$109.20
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 12/19/2025 | A · Award | +1.74K | — | — | 6.7% | 25.82K | 27.55K |
| Common Shares Direct | 12/19/2025 | F · Tax Withholding | −65.00 | $1.68 | $109.20 | 0.2% | 27.55K | 27.49K |
| Total | +1.67K | -$109.20 | ||||||
Derivative Transactions0
No derivative transactions reported